List of Studies ( Metabolite:PE P-40:5 or PE O-40:6)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003057 | AN005012 | Spatiotemporal mapping of lipid disturbance in heart injury - Part 1 | Heart | Mouse | Heart injury | National University of Singapore | LC-MS |
| ST002817 | AN004585 | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics | Heart | Mouse | Cardiomyopathy | University of California, San Francisco | LC-MS |
| ST002764 | AN004498 | Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort | Blood | Human | Cancer | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002764 | AN004499 | Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort | Blood | Human | Cancer | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002700 | AN004376 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics | Blood | Human | Autism | Columbia University | LC-MS |
| ST002700 | AN004377 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics | Blood | Human | Autism | Columbia University | LC-MS |
| ST002002 | AN003265 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 3) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | LC-MS |
| ST001942 | AN003186 | Lipidomics of esophageal adenocarcinoma | Esophagus | Human | Cancer | QIMR Berghofer Medical Research Institute | LC-MS |
| ST001888 | AN003059 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001888 | AN003060 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Blood | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Liver | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001815 | AN002946 | Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | GC-MS/LC-MS |
| ST001815 | AN002947 | Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | GC-MS/LC-MS |
| ST001637 | AN002677 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001637 | AN002678 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001246 | AN002070 | TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes (part-I) | Cultured cells | Human | Sudden infant death syndrome | University of California, Davis | LC-MS |
| ST001211 | AN002018 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Human | University of Kansas | GC-MS/LC-MS | |
| ST001211 | AN002019 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Human | University of Kansas | GC-MS/LC-MS | |
| ST001165 | AN001926 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-III) | Whole animals | Dungeness crab | NOAA NWFSC | LC-MS | |
| ST001165 | AN001927 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-III) | Whole animals | Dungeness crab | NOAA NWFSC | LC-MS | |
| ST001102 | AN001792 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-II) | Whole animals | Dungeness crab | NOAA NWFSC | LC-MS | |
| ST000991 | AN001617 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) | Blood | Human | University of California, Davis | LC-MS | |
| ST000990 | AN001616 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000989 | AN001615 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000988 | AN001614 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) | Blood | Human | University of California, Davis | LC-MS | |
| ST000986 | AN001612 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) | Blood | Human | University of California, Davis | LC-MS | |
| ST000985 | AN001611 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) | Blood | Human | University of California, Davis | LC-MS | |
| ST000984 | AN001610 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) | Blood | Human | University of California, Davis | LC-MS | |
| ST000983 | AN001609 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) | Blood | Human | University of California, Davis | LC-MS | |
| ST000423 | AN000671 | Differences in mycoplasma growth due to different mediums | Cells | Mouse | University of California, Davis | LC-MS | |
| ST000423 | AN000672 | Differences in mycoplasma growth due to different mediums | Cells | Mouse | University of California, Davis | LC-MS | |
| ST000354 | AN000578 | Metabolite comparison of mouse gastric tissue and glands | Stomach | Mouse | University of California, Davis | LC-MS | |
| ST000342 | AN000554 | Renal metabolic pathways indicating ischemic or inflammatory changes | Kidney | Human | Acute kidney injury | University of California, Davis | LC-MS |
| ST000339 | AN000550 | Metabolites in peritoneal macrophages and bone marrow derived macrophages | Cells | Mouse | University of California, Davis | LC-MS | |
| ST000339 | AN000551 | Metabolites in peritoneal macrophages and bone marrow derived macrophages | Cells | Mouse | University of California, Davis | LC-MS | |
| ST000332 | AN000531 | Effects of Giardia intestinalis on mice GI tract | Small intestine | Mouse | Giardia infection | University of California, Davis | LC-MS |
| ST000332 | AN000532 | Effects of Giardia intestinalis on mice GI tract | Small intestine | Mouse | Giardia infection | University of California, Davis | LC-MS |
| ST000331 | AN000529 | Effects of Zinc on GI tract metabolites (Part 2: Prostate) | Prostate | Mouse | University of California, Davis | LC-MS | |
| ST000331 | AN000530 | Effects of Zinc on GI tract metabolites (Part 2: Prostate) | Prostate | Mouse | University of California, Davis | LC-MS | |
| ST000330 | AN000527 | Effects of Zinc on GI tract metabolites | Esophagus | Mouse | University of California, Davis | LC-MS | |
| ST000330 | AN000528 | Effects of Zinc on GI tract metabolites | Esophagus | Mouse | University of California, Davis | LC-MS | |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Colon | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Duodenum | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Ileum | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000523 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Rectum | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000524 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Colon | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000524 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Duodenum | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000524 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Ileum | Dog | University of California, Davis | LC-MS | |
| ST000328 | AN000524 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Rectum | Dog | University of California, Davis | LC-MS | |
| ST000323 | AN000514 | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 2:Uterine flush) | Uterine fluid | Cow | University of California, Davis | LC-MS | |
| ST000321 | AN000510 | Effects of LGG on current drinkers gut metabolism | Feces | Mouse | Alcoholism | University of California, Davis | LC-MS |
| ST000081 | AN000131 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of subcutaneous and visceral adipose tissue samples | Adipose tissue | Human | Cancer | University of California, Davis | LC-MS |
| ST000077 | AN000123 | Metabolite changes associated with methionine stress sensitivity of cancer (CSH QTOF MS analysis) | Breast cancer cells | Human | Cancer | University of California, Davis | LC-MS |
